Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.
Wang L, Shao X, Zhong T, Wu Y, Xu A, Sun X, Gao H, Liu Y, Lan T, Tong Y, Tao X, Du W, Wang W, Chen Y, Li T, Meng X, Deng H, Yang B, He Q, Ying M, Rao Y.
Wang L, et al. Among authors: liu y.
Nat Chem Biol. 2021 May;17(5):567-575. doi: 10.1038/s41589-021-00742-5. Epub 2021 Mar 4.
Nat Chem Biol. 2021.
PMID: 33664520